181 related articles for article (PubMed ID: 11881730)
21. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.
Ohsawa M; Nakatsuka S; Kanno H; Miwa H; Kojya S; Harabuchi Y; Yang WI; Aozasa K
Int J Cancer; 1999 Jun; 81(6):865-70. PubMed ID: 10362131
[TBL] [Abstract][Full Text] [Related]
22. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
24. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
26. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus.
Nagata H; Konno A; Kimura N; Zhang Y; Kimura M; Demachi A; Sekine T; Yamamoto K; Shimizu N
Blood; 2001 Feb; 97(3):708-13. PubMed ID: 11157488
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
28. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
[TBL] [Abstract][Full Text] [Related]
29. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
García-Cosío M; Santón A; Méndez MC; Rivas C; Martín C; Bellas C
Tumori; 2003; 89(3):278-84. PubMed ID: 12908783
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
32. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
34. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-positive T-cell lymphoma cells having chromosome 22q11.2 deletion: an autopsy report of DiGeorge syndrome.
Itoh S; Ohno T; Kakizaki S; Ichinohasama R
Hum Pathol; 2011 Dec; 42(12):2037-41. PubMed ID: 21683977
[TBL] [Abstract][Full Text] [Related]
36. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
Kuo TT; Shih LY; Tsang NM
Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-positive blastoid nasal T/natural killer-cell lymphoma in a caucasian.
Ling TC; Harris M; Craven NM
Br J Dermatol; 2002 Apr; 146(4):700-3. PubMed ID: 11966709
[TBL] [Abstract][Full Text] [Related]
38. Detection of epstein-barr virus in nasal T-cell lymphoma.
Makoshi T; Takahashi H; Kameya T; Yao K; Sato Y; Nakayama M; Tsuchiya B; Okamoto M
Acta Otolaryngol Suppl; 2002; (547):46-9. PubMed ID: 12212593
[TBL] [Abstract][Full Text] [Related]
39. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
40. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Ando S; Kawada JI; Watanabe T; Suzuki M; Sato Y; Torii Y; Asai M; Goshima F; Murata T; Shimizu N; Ito Y; Kimura H
Oncotarget; 2016 Nov; 7(47):76793-76805. PubMed ID: 27732937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
